Schedule 13G ownership disclosure

GALENA BIOPHARMA INC

Security class unavailable · CUSIP: 363256504

Event date: 2017-02-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,980,000
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-010035
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
Feb 17, 2017
Reporting period
Feb 08, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub